Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inci Yildirim

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Journal of the Pediatric Infectious Diseases Society|November 8, 2024
Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal NetworkRobert F T Bucayu, Craig L K Boge, Inci Yildirim, et al.
Microorganisms|April 30, 2021
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE ProjectMaria Garcia Quesada, Yangyupei Yang, Julia C Bennett, et al.
Journal of the Pediatric Infectious Diseases Society|August 10, 2021
Comparative Effectiveness of Echinocandins vs Triazoles or Amphotericin B Formulations as Initial Directed Therapy for Invasive Candidiasis in Children and AdolescentsBrian T Fisher, Theoklis E Zaoutis, Rui Xiao, et al.
Journal of the Pediatric Infectious Diseases Society|August 17, 2023
Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal NetworkRachel L Wattier, Robert F T Bucayu, Craig L K Boge, et al.
The Journal of Infection|January 26, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE projectYangyupei Yang, Maria Deloria Knoll, Carly Herbert, et al.
The Lancet. Infectious Diseases|December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisJulia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
Microorganisms|April 3, 2021
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE ProjectJulia C Bennett, Marissa K Hetrich, Maria Garcia Quesada, et al.
Microorganisms|April 30, 2021
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) ProjectMaria Deloria Knoll, Julia C Bennett, Maria Garcia Quesada, et al.
The Lancet. Infectious Diseases|December 20, 2024
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysisMaria Garcia Quesada, Meagan E Peterson, Julia C Bennett, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Journal of the Pediatric Infectious Diseases Society|November 8, 2024
Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal NetworkRobert F T Bucayu, Craig L K Boge, Inci Yildirim, et al.
Microorganisms|April 30, 2021
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE ProjectMaria Garcia Quesada, Yangyupei Yang, Julia C Bennett, et al.
Journal of the Pediatric Infectious Diseases Society|August 10, 2021
Comparative Effectiveness of Echinocandins vs Triazoles or Amphotericin B Formulations as Initial Directed Therapy for Invasive Candidiasis in Children and AdolescentsBrian T Fisher, Theoklis E Zaoutis, Rui Xiao, et al.
Journal of the Pediatric Infectious Diseases Society|August 17, 2023
Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal NetworkRachel L Wattier, Robert F T Bucayu, Craig L K Boge, et al.
The Journal of Infection|January 26, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE projectYangyupei Yang, Maria Deloria Knoll, Carly Herbert, et al.
The Lancet. Infectious Diseases|December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisJulia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
Microorganisms|April 3, 2021
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE ProjectJulia C Bennett, Marissa K Hetrich, Maria Garcia Quesada, et al.
Microorganisms|April 30, 2021
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) ProjectMaria Deloria Knoll, Julia C Bennett, Maria Garcia Quesada, et al.
The Lancet. Infectious Diseases|December 20, 2024
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysisMaria Garcia Quesada, Meagan E Peterson, Julia C Bennett, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 15